Microplate-based automatic blood grouping analyzer Metis of Aikang MedTech Co., Ltd. (henceforth referred to as Aikang) received approval for marketing in 2015; and its MGT-based automatic blood grouping analyzer Aigel received approval for marketing in 2016.

Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

The director of Columbia University’s Center for Infection and Immunity talked about problems with antigen tests and the need for continued investment in COVID-19 testing.

A new study published in Science Advances outlines the most comprehensive data on the effects of COVID-19 vaccines on menstrual cycles to date.

On July 13, Basecare and Haier formally signed a strategic cooperation agreement in Qingdao, Shandong, China.

Two SARS-CoV-2 antigen tests from Watmind USA and Genabio Diagnostics have received Emergency Use Authorization from the US Food and Drug Administration for at-home use without a prescription.

Quest Diagnostics said Wednesday that it has internally developed a test for monkeypox and launched it, while it also plans to begin offering the US Centers for Disease Control and Prevention's monkeypox test next month.

In 2021, the total number of visits to medical and health institutions in nationwide was 8.47 billion, a year-on-year increase of 9.4%. The average citizen visits medical and health institutions 6 times a year.

Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.

Twist Bioscience and DNAnexus said on Wednesday that they are collaborating on data analysis to help customers develop next-generation sequencing-based diagnostics.

Recently, Hotgen Coronavirus (2019-nCoV)-Antigentest has officially passed 3a validation of the UK Department of Health and Social Care (DHSC), which proves that the antigen test not only has high specificity, but also has high detection sensitivity.

UK-based startup Tailor Bio has received ￡650,000 ($771,767) through the Innovate UK Biomedical Catalyst Award in support of its ambitions to develop a pan-cancer precision medicine platform.